Human VGF-Derived Antidepressant Neuropeptide TLQP62 Promotes SH-SY5Y Neurite Outgrowth.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Human VGF-Derived Antidepressant Neuropeptide TLQP62 Promotes SH-SY5Y Neurite Outgrowth.
- Published In:
- Journal of molecular neuroscience : MN, 70(8), 1293-1302 (2020)
- Authors:
- Moutinho, Daniela, Veiga, Sónia, Requena, Jesús R
- Database ID:
- RPEP-05014
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05014APA
Moutinho, Daniela; Veiga, Sónia; Requena, Jesús R. (2020). Human VGF-Derived Antidepressant Neuropeptide TLQP62 Promotes SH-SY5Y Neurite Outgrowth.. Journal of molecular neuroscience : MN, 70(8), 1293-1302. https://doi.org/10.1007/s12031-020-01541-8
MLA
Moutinho, Daniela, et al. "Human VGF-Derived Antidepressant Neuropeptide TLQP62 Promotes SH-SY5Y Neurite Outgrowth.." Journal of molecular neuroscience : MN, 2020. https://doi.org/10.1007/s12031-020-01541-8
RethinkPeptides
RethinkPeptides Research Database. "Human VGF-Derived Antidepressant Neuropeptide TLQP62 Promote..." RPEP-05014. Retrieved from https://rethinkpeptides.com/research/moutinho-2020-human-vgfderived-antidepressant-neuropeptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.